Related Experiment Video
Updated: Apr 20, 2026

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Role of sevoflurane in organ protection during cardiac surgery in children: a randomized controlled trial
Dominique A Bettex1, Patrick M Wanner2, Marco Bosshart3
1Department of Anaesthesiology, University Hospital Zurich, Zurich, Switzerland Department of Anaesthesiology, University Children's Hospital Zurich, Zurich, Switzerland dominique.bettex@usz.ch.
Insights
Sevoflurane did not offer superior heart protection in pediatric cardiac surgery. However, it may benefit infants under six months compared to midazolam, warranting further investigation in specific groups.
Area of Science:
- Cardiology
- Anesthesiology
- Pediatric Surgery
Background:
- Volatile anesthetics show in vitro protective effects against ischemia-reperfusion injury, but clinical results vary.
- Clinical evidence on sevoflurane's cardioprotective benefits in pediatric cardiac surgery remains inconclusive.
- This study investigates sevoflurane's efficacy compared to total intravenous anesthesia (TIVA) in children undergoing cardiopulmonary bypass (CPB).
Purpose of the Study:
- To determine if sevoflurane provides superior cardioprotection compared to TIVA in pediatric cardiac surgery.
- To evaluate perioperative cardiac function, clinical outcomes, and organ function as secondary endpoints.
- To explore potential subgroup benefits of sevoflurane in pediatric patients.
Main Methods:
- A randomized controlled trial involving 60 children with heart defects undergoing elective cardiac surgery on CPB.
- Patients were randomized to receive either sevoflurane or TIVA (midazolam or propofol based on age).
- Primary endpoint was postoperative peak cardiac troponin I/T; secondary endpoints included cardiac function, clinical outcomes, and organ function.
Main Results:
- No significant difference in peak troponin levels or secondary outcomes between sevoflurane and TIVA groups overall.
- A subgroup analysis revealed significantly lower postoperative troponin levels in acyanotic infants under 6 months who received sevoflurane compared to midazolam.
- No differences in secondary outcomes were observed in this subgroup.
Conclusions:
- Sevoflurane did not demonstrate superior myocardial protection in the general pediatric cardiac surgical population.
- Sevoflurane may offer a cardioprotective benefit in acyanotic infants under six months compared to midazolam.
- Further research is needed to explore the conditioning effects of sevoflurane in specific pediatric subgroups.
Objectives:
The protective effects of volatile anaesthetics against ischaemia-reperfusion injury have been shown in vitro, but clinical studies have yielded variable results. We hypothesized that, in children, sevoflurane provides superior cardioprotection after cardiac surgery on cardiopulmonary bypass (CPB) compared with totally intravenous anaesthesia (TIVA).
Methods:
In this randomized controlled, single-centre study, 60 children with cyanotic and acyanotic heart defects undergoing elective cardiac surgery under CPB (RACHS-1 1-3) were randomized to sevoflurane or TIVA (midazolam <6 months of age, propofol >6 months of age). The primary end-point was the postoperative peak cardiac troponin I/T (cTnI/T). Perioperative cardiac function (as determined by brain-type natriuretic peptide, echocardiography and postoperative vasopressor/inotrope requirements), short-term clinical outcomes (duration of intubation, intensive care unit and hospital length of stay), postoperative inflammatory profile, and pulmonary, renal and liver function were defined as secondary end-points. Analysis of variance was used for statistical analysis.
Results:
There was no statistically significant difference in postoperative peak troponin values or any of the secondary end-points. In the subgroup of acyanotic patients under 6 months, sevoflurane led to significantly lower postoperative troponin levels compared with midazolam [reduction of 54% (95% confidence interval 29-71%, P = 0.002)], without any differences in secondary outcome parameters.
Conclusions:
Sevoflurane did not provide superior myocardial protection in our general paediatric cardiac surgical population. In children under 6 months, however, sevoflurane might be beneficial in comparison with midazolam. The conditioning effects of sevoflurane in specific paediatric subgroups need to be further investigated.
More Related Videos
04:56In Vitro Method to Control Concentrations of Halogenated Gases in Cultured Alveolar Epithelial Cells
Published on: October 23, 2018
03:02Application of Dixon's Up-and-Down Design to Estimate the Minimum Alveolar Concentration of Sevoflurane in Rats with Refined Movement Classification
Published on: July 25, 2025
Related Concept Videos
Inhalational Anesthetics: Overview
Parenteral Anesthetics: Overview
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Stages of General Anesthesia
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiopulmonary Resuscitation IV: Pharmacological Management